Supporting health crisis management, providing tools to collect the data needed to analyze the dynamics of the epidemic: in 2020, COVID-19 was at the heart of Epiconcept’s e-health activity. We provide a retrospective of the projects put into production for our clients, before a transition to 2021 where public health professionals will face a major challenge: vaccination campaigns against COVID-19.
Screening management: a “Drive COVID-19” information system for Bioliance
During the first containment in France, the Bioliance network set up a Drive system in its medical laboratories’ parking lors. The device made it possible to collect nasopharyngeal samples from city patients under optimal air/contact precautionary conditions.
Bioliance asked Epiconcept to deploy a workflow that would minimize the use of paper and therefore physical contact, reduce the bottleneck of patient recall and secure the collection of information, without feeding the bases of an intermediary.
The workflow covered the following fields:
– Before the laboratory appointment: sample request form to be filled in by the general practitioner during consultations or teleconsultations; generation of an automatic e-mail for the patient, with a file to be completed for the sample appointment; transmission flow of the patient file to the laboratory;
– For the laboratories themselves, in the laboratory information systems: interface for making appointments and recording the patient file.
A Health Preventative Suite adapted COVID-19 screening and new consultation uses
This year, the Preventative Health Suite has continuously adapted to the emerging needs of its users, particularly in relation to the COVID-19 epidemic. Among its evolutions, we can mention:
– A module intended for future COVID-19 screening centers (appointment scheduling manager, COVID-19 virtual waiting room, COVID-19 questionnaire, COVID-19 TROD/serology/PCR realization, printing of an attestation and other documents, statistics and data exports on COVID-19 activity, integration of laboratory results).
– An additional “Tele-consultation” field to notify appointments made by telephone or videoconference. It can be ticked in the consultation information and now appears in the existing work lists, so that the activity carried out via this mode can be measured.
Epiconcept is in a position to equip new centers conducting COVID-19 screening. If you are concerned, you can contact us at the following address: firstname.lastname@example.org.
COVID-19 and Confinement: A Large-Scale French Survey to understand the epidemiological and social stakes
The multidisciplinary SAPRIS survey was launched in April to understand the epidemiological and social challenges of the exceptional measures (including containment) put in place to fight the COVID-19 pandemic. It involved nearly 200,000 participants from five large French national cohorts (Constances – Family Study E3N-E4N – Elf / Epipage 2 – NutriNet Santé – whose living conditions were already assessed a priori). The points studied were the incidence of symptoms of COVID-19 or other health problems, recourse to or renunciation of care for other pathologies, risk perception, effects of preventive measures, etc.
The entire collection system was built from the Epiconcept Voozanoo platform and its e-cohorte modules.
For more information, please visit the Inserm website.
An information system to investigate the communication conditions of health care personnel
Mid-April, GERES (a French Study Group on the Risk of Exposure of Caregivers to Infectious Agents) launched a public research project aimed at analyzing the contamination context of health care personnel, whether they work in health care institutions, in the medical and social sector or in cities. They are invited to answer a qualitative questionnaire developed with Epiconcept’s Voozanoo information system. This survey is supported by the Haute Autorité de Santé and Santé Publique France.
The initial findings (based on the responses of 2,329 professionals contaminated during the first wave) were revealed in early December in a weekly surveillance bulletin published by Santé Publique France. The analysis reveals significant differences in the use of protective masks adapted to the risk of infection. They must be related to the availability of this equipment and the recommendations or protocols used, which vary according to the type of establishment and the sector of activity over the period February – April 2020 (which represents 96% of the respondents’ contaminations).
The survey continues until April 2021.
A special COVID-19 questionnaire integrated into the COSET program
In order to improve the epidemiological surveillance of occupational risks in France, Santé Publique France has set up a system for monitoring the health of the population in relation to work: the COSET program (Cohorts for Epidemiological Surveillance in Relation to Work). It is aimed at self-employed workers and workers in the agricultural sector and aims to describe and monitor the links between occupational factors and the occurrence of health problems (muscular and joint, mental health, cardiovascular and respiratory, cancers, etc.).
In May 2020, Epiconcept supported the development of an online questionnaire for program participants. In addition to questions related to lifestyle habits, it aimed to study the impact of the COVID-19 epidemic on their health and professional situation.
The collection of responses took place between late May and early August. The results of the survey will be made public as soon as possible.
A Consortium to Support Resource-Constrained Countries in the Response to the COVID-19 Crisis
In June, Epiconcept Group joined three organisations (CREDES, an international operator for the reinforcement of the supply and quality of public policies in Health, the Humanitarian Centre for Pharmaceutical Professions (Centre Humanitaire des Métiers de la Pharmacie), a non-profit association with pharmaceutical and health products expertise, and Integrated Quality Laboratory Services, a research, consulting and expertise office in laboratory activities) to form a consortium. It offers support and consulting in the deployment of adapted public policies in the response to the COVID-19 crisis in countries with limited resources. Check this article for further information.
Vaccines against Covid-19: COVIREIVAC, a platform to recruit 25,000 volunteers to conduct large-scale clinical trials in France
At the request of the Ministry of Solidarity and Health and the Ministry of Higher Education and Research, France has organized itself to contribute to the evaluation of the most promising vaccine candidates with the establishment of the COVIREIVAC platform.
Piloted by Inserm, COVIREIVAC federates 24 clinical investigation centers within university hospitals throughout France, in close collaboration with the National College of Teaching General Practitioners. The clinical operational aspects of the various university hospitals are coordinated by Assistance Publique – Hôpitaux de Paris.
The information system designed to register volunteers to conduct the first large-scale clinical trials in France was developed by Epiconcept. It can be accessed online at www.covireivac.fr.